Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.

Buse, John B; Bergenstal, Richard M; Glass, Leonard C; Heilmann, Cory R; Lewis, Michelle S; Kwan, Anita Y M; Hoogwerf, Byron J; Rosenstock, Julio
Annals of internal medicine; 2011 Jan 18;154(2):103-12. PMID: 21138825
University of North Carolina School of Medicine, Chapel Hill, 27599, USA.


Insulin replacement in diabetes often requires prandial intervention to reach hemoglobin A₁(c) (HbA₁(c)) targets.